TCM Biotech International

CompanyTaiwan

TCM Biotech International develops one asset, in human trials (LivPhcD in NAFLD). Mostly supplement; based in Taiwan.

1
Asset
Furthest stage
Human trials
1
Trial
0
Signals

Pipeline

1
  • LivPhcD

    Hepatoprotective dietary supplement for non-alcoholic fatty liver disease.

    Human trials, Supplement, NAFLD

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Similar companies2

Intelligence